Total Payments
$1,776
2024 Payments
$310.82
Companies
21
Transactions
91
Medicare Patients
1,281
Medicare Billing
$234,411
Payment Breakdown by Category
Food & Beverage$1,776 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,776 | 91 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $818.42 | 43 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $163.19 | 17 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $113.36 | 1 | $0 (2024) |
| Novo Nordisk Inc | $91.49 | 1 | $0 (2021) |
| Allergan, Inc. | $75.36 | 3 | $0 (2020) |
| Lilly USA, LLC | $57.63 | 3 | $0 (2022) |
| Biogen, Inc. | $51.11 | 3 | $0 (2021) |
| Amgen Inc. | $47.07 | 2 | $0 (2022) |
| Daiichi Sankyo Inc. | $44.19 | 2 | $0 (2023) |
| Ultragenyx Pharmaceutical Inc. | $42.56 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.82 | 5 | ABBVIE INC. ($181.02) |
| 2023 | $276.11 | 16 | AbbVie Inc. ($214.81) |
| 2022 | $150.18 | 8 | Amgen Inc. ($47.07) |
| 2021 | $877.00 | 54 | AbbVie Inc. ($387.85) |
| 2020 | $162.19 | 8 | Allergan, Inc. ($75.36) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $113.36 | General |
| Category: Respiratory | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $150.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes Care | ||||||
| 01/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes Care | ||||||
| 08/02/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $22.80 | General |
| Category: non-opioid analgesic | ||||||
| 06/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/30/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2022 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Analgesic | ||||||
| 09/21/2022 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Neuroscience | ||||||
| 08/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 372 | 901 | $157,527 | $65,722 |
| 2022 | 6 | 327 | 937 | $192,598 | $78,408 |
| 2021 | 8 | 375 | 799 | $157,612 | $69,361 |
| 2020 | 7 | 207 | 280 | $48,434 | $20,919 |
Total Patients
1,281
Total Services
2,917
Medicare Billing
$234,411
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 618 | $123,650 | $53,926 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $19,300 | $8,452 | 43.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 66 | $6,600 | $2,212 | 33.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 70 | 107 | $4,790 | $898.80 | 18.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 19 | $2,577 | $185.60 | 7.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $610.00 | $47.74 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 706 | $158,064 | $65,105 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $22,918 | $9,433 | 41.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 43 | 75 | $7,625 | $3,282 | 43.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 11 | $1,650 | $384.38 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 41 | 47 | $1,708 | $139.20 | 8.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 19 | $633.00 | $65.39 | 10.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 124 | 509 | $110,834 | $50,797 | 45.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 76 | 76 | $21,216 | $8,706 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 78 | $12,307 | $5,326 | 43.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 33 | 33 | $4,553 | $2,059 | 45.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 24 | $2,434 | $1,110 | 45.6% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 22 | 22 | $3,160 | $777.26 | 24.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 19 | 28 | $1,813 | $498.42 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 28 | 29 | $1,296 | $87.00 | 6.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 116 | $23,550 | $10,541 | 44.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 51 | 51 | $13,550 | $5,988 | 44.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 27 | 29 | $4,930 | $2,176 | 44.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 23 | 24 | $3,160 | $1,366 | 43.2% |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | Office | 2020 | 12 | 12 | $1,300 | $430.92 | 33.1% |
About Dr. Sohaib Siddiqui, MD
Dr. Sohaib Siddiqui, MD is a Family Medicine healthcare provider based in North Conway, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073712725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sohaib Siddiqui, MD has received a total of $1,776 in payments from pharmaceutical and medical device companies, with $310.82 received in 2024. These payments were reported across 91 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,776).
As a Medicare-enrolled provider, Siddiqui has provided services to 1,281 Medicare beneficiaries, totaling 2,917 services with total Medicare billing of $234,411. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location North Conway, NH
- Active Since 07/13/2007
- Last Updated 07/29/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073712725
Products in Payments
- VRAYLAR (Drug) $555.54
- UBRELVY (Drug) $303.50
- AJOVY (Biological) $149.17
- BREZTRI (Drug) $113.36
- RYBELSUS (Drug) $91.49
- EMGALITY (Drug) $57.63
- Otezla (Drug) $47.07
- INJECTAFER (Drug) $44.19
- NURTEC ODT (Drug) $41.34
- FREESTYLE LIBRE 3 (Device) $35.53
- QULIPTA (Drug) $34.74
- Dayvigo (Drug) $23.24
- LICART (Drug) $22.80
- XARELTO (Drug) $21.61
- STANDARD RF DISPOSABLES (Device) $21.32
- GENERATOR (Device) $20.49
- COLOGUARD DNA CAPTURE REAGENTS (Device) $20.04
- BELBUCA (Drug) $18.97
- FLUZONE QUADRIVALENT (Biological) $17.17
- ZTLido (Drug) $15.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in North Conway
James Glazer, Md, MD
Family Medicine — Payments: $48,238
Family Medicine $48,238
Dr. Brian Sponseller, Md, MD
Family Medicine — Payments: $15,816
Family Medicine $15,816
Dr. William Martin, Md, MD
Family Medicine — Payments: $5,468
Family Medicine $5,468
Michael Badger, M.d, M.D
Family Medicine — Payments: $985.05
Family Medicine $985.05
Jennifer Smith, Do, DO
Family Medicine — Payments: $803.90
Family Medicine $803.90
Craig Smith, D.o, D.O
Family Medicine — Payments: $510.40
Family Medicine $510.40